US Patent 11584800 Method of treating cancer comprising administration of anti-HER2 antibody-drug conjugate

Patent 11584800 was granted and assigned to Daiichi Sankyo on February, 2023 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Daiichi Sankyo

Current Assignee

Daiichi Sankyo

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

11584800

Date of Patent

February 21, 2023

Patent Application Number

16997613

Date Filed

August 19, 2020

Patent Citations

‌

US Patent 10227417 Anti-TROP2 antibody-drug conjugate

‌

US Patent 10195288 Antibody-drug conjugate

‌

US Patent 10383878 Anti-HER3 antibody-drug conjugate

Patent Primary Examiner

‌

Patricia Duffy

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11584800 Method of treating cancer comprising administration of anti-HER2 antibody-drug conjugate

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API